.. container::

   .. container::

      ===== ===============
      Lanza R Documentation
      ===== ===============

      .. rubric:: Prevention of Gastointestinal Damages
         :name: prevention-of-gastointestinal-damages

      .. rubric:: Description
         :name: description

      Data from four randomised clinical trials on the prevention of
      gastointestinal damages by Misoprostol reported by Lanza et al.
      (1987, 1988a,b, 1989).

      .. rubric:: Usage
         :name: usage

      .. code:: R

         data("Lanza")

      .. rubric:: Format
         :name: format

      A data frame with 198 observations on the following 3 variables.

      ``study``
         a factor with levels ``I``, ``II``, ``III``, and ``IV``
         describing the study number.

      ``treatment``
         a factor with levels ``Misoprostol`` ``Placebo``

      ``classification``
         an ordered factor with levels ``1`` < ``2`` < ``3`` < ``4`` <
         ``5`` describing an ordered response variable.

      .. rubric:: Details
         :name: details

      The response variable is defined by the number of haemorrhages or
      erosions.

      .. rubric:: Source
         :name: source

      F. L. Lanza (1987), A double-blind study of prophylactic effect of
      misoprostol on lesions of gastric and duodenal mucosa induced by
      oral administration of tolmetin in healthy subjects. *British
      Journal of Clinical Practice*, May suppl, 91–101.

      F. L. Lanza, R. L. Aspinall, E. A. Swabb, R. E. Davis, M. F. Rack,
      A. Rubin (1988a), Double-blind, placebo-controlled endoscopic
      comparison of the mucosal protective effects of misoprostol versus
      cimetidine on tolmetin-induced mucosal injury to the stomach and
      duodenum. *Gastroenterology*, **95**\ (2), 289–294.

      F. L. Lanza, K. Peace, L. Gustitus, M. F. Rack, B. Dickson
      (1988b), A blinded endoscopic comparative study of misoprostol
      versus sucralfate and placebo in the prevention of aspirin-induced
      gastric and duodenal ulceration. *American Journal of
      Gastroenterology*, **83**\ (2), 143–146.

      F. L. Lanza, D. Fakouhi, A. Rubin, R. E. Davis, M. F. Rack, C.
      Nissen, S. Geis (1989), A double-blind placebo-controlled
      comparison of the efficacy and safety of 50, 100, and 200
      micrograms of misoprostol QID in the prevention of
      ibuprofen-induced gastric and duodenal mucosal lesions and
      symptoms. *American Journal of Gastroenterology*, **84**\ (6),
      633–636.

      .. rubric:: Examples
         :name: examples

      .. code:: R

           data("Lanza", package = "HSAUR")
           layout(matrix(1:4, nrow = 2))
           pl <- tapply(1:nrow(Lanza), Lanza$study, function(indx)
               mosaicplot(table(Lanza[indx,"treatment"], 
                                Lanza[indx,"classification"]),
                          main = "", shade = TRUE))
